Table 2 Functional mapping and annotation of UKBB GWAS and meta-analysis.

From: Genomic influences on self-reported childhood maltreatment

Sample

GWAS hit lead variant

GWAS p-value

Position (hg19)

#SNPs in LD (r2 > 0.6)

Genomic coordinated risk locus (hg19)

Predicted genes in risk locus

SNPs in LD with CADD scores > 12.37

SNPs in LD with RegulomeDB scores < 5

Chromatin state analysis (Roadmap Epigenomics) in neuronal cell lines/tissuesa

eQTL (28 neuronal tissue/cell lines from CommonMind Consortium, BRAINEAC or GTEx v7)

UKBB GWAS

rs142346759

4.35E−08

3: 71362232

5

chr3:71355932–71417539

FOXP1 intronic

rs34936081

rs13083684 (intronic)

Mainly quiecent

None

rs10262462

4.36E−08

7: 114180062

77

chr7:114015707–114287116

FOXP2 intronic

rs7785701,rs6466488,rs10249234,rs9332390,rs66823671,rs12533005

rs2396753 (intronic), rs12536335 (intronic)

Mainly quiecent

None

Meta-analysis

rs1859100

3.91E−08

7: 114194615

74

chr7:114015707–114287116

FOXP2 intronic

rs66823671,rs71149745,rs7785701,rs12533005,rs9332390,rs10249234, rs1476535, rs6466488

rs2396753 (intronic), rs12536335 (intronic), rs9332390 (intronic)

Mainly quiecent

None

rs917577

2.64E−08

12:126548817

27

chr12:126548816–126585545

Intergenic

None

None

Mainly quiecent

None

  1. aIn neuronal cell lines/tissues E053, E054, E067, E068, E069, E070, E071, E072, E073, E074, E081, E082, E125